HIVST INDICATORS Sample Clauses

HIVST INDICATORS. There are a number of established indicators recognized by the WHO and PEPFAR to track the success of HIVST in particular, along with linkage to prevention and treatment. Many of these metrics can be obtained using routine clinic data, specifically: • Reach: Which distribution strategies are most effective for reaching the undiagnosed? » Uptake of HIVST by priority population: adult males, adolescent girls and young women, adolescent boys and young men, » HIV testing coverage among priority populations » HIV testing uptake among index cases following HIVST » Uptake of HIVST among first-time testers • Outcome of HIVST: reactive and non-reactive (negative) HIVST (can be collected with directly assisted, on-site HIVST and via direct follow up with the self-tester (if HIVST was conducted off-site) or the recipient of the HIVST for secondary distribution (pregnant and post-partum women, who receive HIVST for partner or index clients, who received HIVST kits for distribution among their sexual contacts). • Linkage to HIV care following HIVST: » Uptake of confirmatory testing (can be measured if self-testing is incorporated in clinic data or through direct follow up of HIV Self-test users) » Level of ART initiation following an HIVST (needs to be standardized, per clinic/day ideally) • Linkage to Prevention Services, VMMC and PrEP uptake following HIVST » Uptake of VMMC services following HIVST » Uptake of PrEP services following HIVST • Process: Measuring different steps in the distribution and linkage processes for each of the distribution models to identify bottlenecks to ensure fidelity of the planned HIVST service delivery approaches. The following table summarizes the indicators used for the different HIVST distribution and linkage models described above: 64 HIVST DISTRIBUTION MODEL INDICATOR (* = WHO/PEPFAR REQUIRED) NUMERATOR (N)/ DENOMINATOR (D) MEASUREMENT METHOD AND ISSUES SOURCE All HIVST distribution models Number of HIVST kits distributed* N: Total number of HIVST kits distributed Disaggregation by: age (10–14, 15–19, 20–49, 50+ years), sex and key population, if collected. Disaggregated by testing history (last test in the last 3 months, last 12 months, never tested for HIV before HIVST Routine program data based HIVST registers filled during HIVST kit distribution (for example, using tablet- or paper- based collection tools)PEPFAR Monitoring, Evaluation and Reporting Indicator Reference Guide Disaggregated by approach (e.g., community- based, faci...
Sample 1
AutoNDA by SimpleDocs

Related to HIVST INDICATORS

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!